Psychedelic Drugs Market Will Grow Nearly USD 5.1 Bn At A Rate Of 7.6% By 2032
The psychedelic drugs market has seen a resurgence in recent years, shifting from counterculture to therapeutic potential. Long-used historically in spiritual and cultural contexts, psychedelics gained renewed scientific interest in the 21st century. Promising studies showed their effectiveness in treating depression, anxiety, PTSD, and addiction. Regulatory advancements, like FDA's breakthrough therapy status for psilocybin, have paved the way for more research and investments. Investments and startups have poured into the psychedelics industry, focusing on drug development and treatment centers. The market faces challenges concerning public perception, legal barriers, and equitable access. Ethical considerations regarding research and potential misuse must be…
- Date: August 3, 2023
- Author: Robert Shaw
- Category: Taiwan News